Literature DB >> 27219841

Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations.

Kazuki Nabeshima1, Shinji Matsumoto1, Makoto Hamasaki1, Tomoyuki Hida1, Toshiaki Kamei2, Kenzo Hiroshima3, Tohru Tsujimura4, Kunimitsu Kawahara5.   

Abstract

Because most of malignant pleural mesothelioma (MPM) patients first present with pleural effusion, detection of mesothelioma cells on effusion smears is critical for early diagnosis. Recently, accumulating evidence indicating that the cytological diagnosis of MPM supported by ancillary techniques is as reliable as that based on histopathology has led to new guidelines for the cytopathologic diagnosis of MPM. Based on the guidelines, a combination of cytomorphological criteria and verification by ancillary techniques is required for the cytologic diagnosis of MPM. Detection of p16 homozygous deletion by fluorescence in situ hybridization (FISH) is the most reliable ancillary technique for differentiating MPM from reactive mesothelial cells (RMC) because of its relatively high sensitivity and extremely high specificity. We showed that the p16 deletion status of MPM cells in pleural effusions reflected that of the underlying invasive MPM tissues, indicating the usefulness of p16 FISH in effusion smear cytology for MPM diagnosis. Thus, for differentiating MPM from RMC, we propose to perform p16 FISH as often as possible. A positive p16 homozygous deletion supports the diagnosis of MPM. However, a negative result does not rule out the possibility of MPM. In such cases, a morphological assessment is critical. Therefore, we analyzed the morphological characteristics of p16 deletion-positive mesothelioma cells using a combination of virtual microscopy and p16 FISH, and identified three morphological characteristics useful for the differentiation, including cell-in-cell engulfment with or without hump formation, multinucleate cells, and larger berry-like cell aggregates. Diagn. Cytopathol. 2016;44:774-780.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ancillary techniques; cytologic diagnosis; fluorescence in situ hybridization; homozygous deletion; malignant pleural mesothelioma; p16 gene

Mesh:

Substances:

Year:  2016        PMID: 27219841     DOI: 10.1002/dc.23501

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma.

Authors:  Navid Sobhani; Silvia P Corona; Fabrizio Zanconati; Daniele Generali
Journal:  Genes Cancer       Date:  2017-03

Review 2.  Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.

Authors:  Rossella Bruno; Greta Alì; Gabriella Fontanini
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

3.  Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion.

Authors:  Takumi Kishimoto; Yoko Kojima; Nobukazu Fujimoto
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

4.  Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures.

Authors:  Kadir Harun Sarun; Kenneth Lee; Marissa Williams; Casey Maree Wright; Candice Julie Clarke; Ngan Ching Cheng; Ken Takahashi; Yuen Yee Cheng
Journal:  Int J Mol Sci       Date:  2018-10-07       Impact factor: 5.923

5.  P16 as a marker of carcinoma in effusions and peritoneal washing.

Authors:  Fabiana Pirani Carneiro; Rivadávio Fernandes Amorim; Marcos de Vasconcelos Carneiro; Tercia Maria Mendes Lousa de Castro; Leonora Maciel de Souza Vianna; Gustavo Henrique Soares Takano; Andersen Charles Daros; Isabela Peres; Selma Aparecida Souza Kuckelhaus; Andrea Barretto Motoyama
Journal:  BMC Cancer       Date:  2020-03-17       Impact factor: 4.430

Review 6.  Extracellular Vesicles-Based Drug Delivery Systems: A New Challenge and the Exemplum of Malignant Pleural Mesothelioma.

Authors:  Stefano Burgio; Leila Noori; Antonella Marino Gammazza; Claudia Campanella; Mariantonia Logozzi; Stefano Fais; Fabio Bucchieri; Francesco Cappello; Celeste Caruso Bavisotto
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.